|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cystic Fibrosis | |||||
| Lung Disease | |||||
| Pseudomonas Infections | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Fibrosis | |||||
| Infection | |||||
| Lung Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Digestive System Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Gram-Negative Bacterial Infections | |||||
| Infant, Newborn, Diseases | |||||
| Pancreatic Diseases | |||||
| Pathologic Processes | |||||
| Respiratory Tract Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| CF newborn screening | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| National Center for Research Resources (NCRR) | |||||